The Chancellor


 Pursuant to Section 30 of the   UNIVERSITIES AND OTHER TERTIARY INSTITUTIONS ACT, 2001, His Excellency the President of Uganda Yoweri Kaguta Museveni, the Visitor to the University has appointed a Second Chancellor of Busitema University. The chancellor has been appointed on the recommendation of Busitema University Council after being nominated by the public. The installation of the Chancellor is this time a unique one as Busitema University is celebrating ten years of existence and at its eighth graduation ceremony.

The Chancellor is the Titular Head of the University and in that capacity confers Degrees in the name of the University to persons who have qualified for the various Awards. The Chancellor, in addition appoints key officials in the University including; the Vice-Chancellor, the Deputy Vice Chancellor and the Chairperson of the University Staff Tribunal.

I take the privilege and honor to introduce Professor Vinand Mukatabala Nantulya who will today Tuesday 3rd October 2017 be installed as the second Chancellor of Busitema University.

 Professor Nantulya is an accomplished scholar, administrator and entrepreneur. He holds a Doctor of Philosophy (PhD) Degree from University of Nairobi specialising in immunology.

He is a Fellow of the Royal College of Pathology, London, a Takemi Fellow and Senior Research Scientist, International Health, Harvard School of Public Health, Boston, USA.

He is a graduate of Doctor of Medicine (MD) from University of Dar es Salaam, Tanzania.

Vinand Mukatabala Nantulya is a career researcher in basic science and international health, with several original research articles in international scientific journals. He has occupied top level international research positions, undertaken many consultancies for governments in Eastern and Southern Africa, US Department of Agriculture, USAID, The Global Fund, and the World Health Organization (WHO).

He has chaired the global Task Force for Retooling TB control, charged with developing a framework for introduction of new vaccines, new diagnostics, and new drugs and into TB control globally as they become available.

Served on many international Boards: as President, Board of Trustees, for a US-based JRS Biodiversity Foundation; Member, Strategic Advisory Board of Thomson Scientific for Academic and Government markets; Member, External Scientific Review Panel for the Swiss Tropical Institute, Basel; Global Fund representative on the Governing Boards of Roll Back Malaria, and Stop TB Partnership; Member of University Council and Appointments Board of Makerere University, Kampala.

Professor Nantulya currently, serves on the Strategy Committee of The Global Fund Board, Geneva, and on the Global Fund Technical Evaluation Reference Group (TERG)

He is a co-founder of Action Africa Help International (AAH-I), a primary health care development and service provider NGO with operations in South Sudan, Uganda, Kenya, Zambia, Somalia, Djibouti and now Ethiopia.

He has served as Chair of the Uganda AIDS Commission, where he got the Commission back on track on its mission and moved to re-engage the key stakeholders in the response. He re-focused the response strategy to prevention and brought the commission nearer to the people.

In 2011, he was elected Chairman of the Global Fund Country Coordination Mechanism (CCM). Over time he has developed the Uganda CCM into a model of excellence for all the CCMs worldwide and it mobilized for Uganda close to 1.6 Billion United States dollars to support the fight against HIV/AIDS, Tuberculosis and Malaria.

Professor Nantulya spearheaded the establishment of an AIDS Trust Fund which eventually was passed by parliament into law. The Trust Fund was intended to be a tool for mobilizing additional domestic funding for HIV/AIDS and related conditions. The Trust Fund is to be managed by the Ministry of Health.

He has worked with the private sector to introduce the One Dollar Initiative (ODI) as another strategy for mobilizing domestic resources through the private sector in support of the national HIV/AIDS response.

Professor Nantulya has established a livestock vaccine manufacturing plant Brentec Investments under incubation by Uganda Industrial Research Institute in Kampala. The first vaccine that is already on the market is a poultry vaccine against Newcastle Disease which is a major constraint to the development of the poultry industry in Uganda and the whole of the sub-Sahara Africa. Two other poultry vaccines are under research and development. He has also established a separate facility, Astel Diagnostics Ltd, a manufacturer of rapid diagnostic tests against a variety of diseases.

Professor NantuIya is the Senior Presidential Advisor on Vaccines and Pharmaceuticals.

Busitema University is proud to have Professor Nantulya as her Chancellor, because he is a Visionary, exceptional and exemplary Leader who will be instrumental in guiding Busitema University. He brings with him a wealth of experience, which will enable him to guide the University as it strives to achieve its Vision of “A Centre of Academic and Professional Excellence in Science, Technology and Innovation’’